Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination. Issue 5 (23rd August 2019)

• Record Type: Journal Article
• Authors: Galloway, Dylan A.; Gowing, Elizabeth; Setayeshgar, Solmaz; Kothary, Rashmi
• Is Part Of: Glia. Volume 68:Issue 5(2020)
• Page Start: 859
• Page End: 877
• Publication Date: 2019-08-23
• Subjects: exercise -- immune system -- microbiome -- microRNA -- myelin repair -- nutrition -- oligodendrocyte; Neuroglia -- Periodicals; Neurology -- Periodicals; 611.0188
• DOI: 10.1002/glia.23711
• Languages: English
• ISSNs: 0894-1491

Abstract

Abstract: Regeneration of myelin, following injury, can occur within the central nervous system to reinstate proper axonal conductance and provide trophic support. Failure to do so renders the axons vulnerable, leading to eventual degeneration, and neuronal loss. Thus, it is essential to understand the mechanisms by which remyelination or failure to remyelinate occur, particularly in the context of demyelinating and neurodegenerative disorders. In multiple sclerosis, oligodendrocyte progenitor cells (OPCs) migrate to lesion sites to repair myelin. However, during disease progression, the ability of OPCs to participate in remyelination diminishes coincident with worsening of the symptoms. Remyelination is affected by a broad range of cues from intrinsic programming of OPCs and extrinsic local factors to the immune system and other systemic elements including diet and exercise. Here we review the literature on these diverse inhibitory factors and the challenges they pose to remyelination. Results spanning several disciplines from fundamental preclinical studies to knowledge gained in the clinic will be discussed. Main points: Lesion‐associated inhibitory factors are a cause of failure of remyelination in multiple sclerosis. Strategies to overcome challenges to remyelination are numerous and diverse, being based on signaling molecules, microRNAs, immune modulators, nutrition, and/or exercise.